Cartilage Repair Technology for Novel Industries and Applications

Publication ID: 24-11857576_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Cartilage Repair Technology for Novel Industries and Applications,” Published Technical Disclosure No. 24-11857576_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857576_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,576.

Summary of the Inventive Concept

The present inventive concept expands the core technology of cartilage repair compositions and methods to novel industries and applications, addressing unmet needs in athletic performance monitoring, veterinary medicine, industrial workplace safety, space exploration, and conservation of exotic species.

Background and Problem Solved

The original patent disclosed compositions and methods for repairing cartilage defects, primarily focusing on human applications. However, the limitations of the original patent lie in its restricted scope, failing to address the broader potential of cartilage repair technology in various industries and fields. The new inventive concept solves this problem by adapting the core technology to entirely different industries, fields, or problems that were not originally considered.

Detailed Description of the Inventive Concept

The new inventive concept encompasses four distinct applications: (1) a system for monitoring and predicting athletic performance, utilizing wearable devices and machine learning algorithms to provide personalized training regimens; (2) a method for treating cartilage defects in horses, adapted for equine use and promoting cartilage repair; (3) a device for repairing cartilage defects in industrial workers, designed for use in industrial settings and reducing workplace injuries; and (4) a system for monitoring cartilage health in astronauts, providing personalized exercise regimens to prevent cartilage degeneration in space. Additionally, the inventive concept includes a method for treating cartilage defects in zoo animals, promoting cartilage repair and conservation.

Novelty and Inventive Step

The new claims introduce novel applications and use cases for the cartilage repair technology, expanding its scope beyond human applications and addressing unmet needs in diverse industries. The inventive step lies in the adaptation of the core technology to these new fields, requiring significant modifications to the compositions and methods to accommodate the unique requirements of each industry.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include adaptations for other animal species, integration with emerging technologies like artificial intelligence or 3D printing, or development of novel biomaterials for cartilage repair. Variations may also include different modes of administration, such as injectable formulations or implantable devices.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including sports medicine, veterinary medicine, industrial safety, space exploration, and conservation. The market for these applications is substantial, with potential customers ranging from professional sports teams to zoos and space agencies.

Field of Art

Regenerative medicine, specifically cartilage repair and tissue engineering, involving cell culture techniques, biomaterial development, and medical device design for orthopedic applications

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or tissue engineering specialist with advanced degrees, expertise in cell culture, biomaterials, and medical device development, familiar with techniques for harvesting, culturing, and applying allogeneic cells in regenerative therapies

Obviousness Rationale

A PHOSITA would recognize that the core cartilage repair technology from the source patent can be readily adapted to different biological contexts by modifying cell culture conditions, delivery mechanisms, and target populations while maintaining the fundamental compositional and methodological principles of the original invention.

Obvious Combinations & Variations

Source Patent Element
Cultured allogeneic chondrocytes from cryogenically frozen cell bank samples
PTD Variation
Applying the same cell culture technique to horse, zoo animal, and industrial worker cartilage repair applications
Obviousness Reasoning
Known cell culture techniques are universally applicable across species, with predictable modifications to accommodate specific biological requirements
Source Patent Element
Resorbable collagen membrane composed of type I and III porcine collagen
PTD Variation
Adapting the membrane composition for different delivery contexts like athletic performance monitoring devices and space exploration systems
Obviousness Reasoning
Biomaterial design principles are transferable across applications, with minor adjustments to accommodate specific mechanical and biological constraints
Source Patent Element
Method of thawing cryogenically frozen cell samples at approximately 37°C
PTD Variation
Extending cell thawing and culture protocols to veterinary, industrial, and space exploration contexts
Obviousness Reasoning
Standard cell culture techniques represent a finite set of known methods that can be predictably applied across different biological systems
Source Patent Element
Treating chondral and osteochondral defects using cultured cells and collagen membrane
PTD Variation
Implementing machine learning algorithms to predict and prevent cartilage defects in athletic and space exploration contexts
Obviousness Reasoning
Integrating predictive technologies with existing medical treatments represents an obvious extension of known diagnostic and preventative strategies
Source Patent Element
Composition for cartilage repair using allogeneic cells
PTD Variation
Creating specialized delivery mechanisms for different industrial and veterinary applications
Obviousness Reasoning
Device design modifications represent predictable engineering adaptations based on specific use case requirements
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857576, a Person Having Ordinary Skill In The Art would find the variations disclosed in the Published Technical Disclosure to represent obvious extensions of the fundamental cartilage repair technology, wherein the core compositional and methodological principles can be readily adapted to diverse biological contexts through predictable modifications in cell culture, biomaterial design, and delivery mechanisms.

Original Patent Information

Patent NumberUS 11,857,576
TitleCompositions and methods for repairing cartilage defects
Assignee(s)Vericel Corporation